MCK vs RXST · P/E 20, rev $403.43B vs rev $64.6M
McKesson Corporation (MCK) versus Rxsight Inc (RXST) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported RXST revenue for 2026-06-30 was $64.6M. Net income was -$28.0M. RXST currently screens at market cap $198.3M.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. RXST currently screens at market cap $198.3M.
Not investment advice. Open the MCK and RXST stock pages for the full models.
Not investment advice.